cp wire

CP Wire Articles

Peloton Therapeutics Initiates Phase II Trials of Treatment for Rare Kidney Cancer

Peloton Therapeutics, Inc., announced on 6/6/2018 the dosing of the first patient in a Phase 2 trial evaluating the efficacy and safety of lead investigational oncology agent, PT2977, to treat von... read more

Wed, 06/6/18 - 09:33 am
Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica
  • Axovant will license two products from Oxford BioMedica
  • The gene therapy based products have demonstrated long term improvement in motor function
  • Axovant shares are up 102%... read more
Wed, 06/6/18 - 09:17 am
BioCryst Urges Stockholders To Vote For Merger With Idera

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst” or the “Company”), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today issued... read more

Tue, 06/5/18 - 09:51 am
Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
  • TRC101 met both primary and secondary endpoints
  • Partients reported improved quality of life scores
  • Approximately 3 million patients in the US alone are at risk for CKD... read more
Tue, 06/5/18 - 09:24 am
EATRIS Announces Novel Public-Private Collaboration for Imaging Method Development in Inflammatory Diseases

International multi-site collaboration hub will implement new clinical imaging tools and deliver several projects per year... read more

Mon, 06/4/18 - 11:15 am

Pages